Filing Details
- Accession Number:
- 0001225208-18-004659
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-28 18:04:46
- Reporting Period:
- 2018-02-26
- Accepted Time:
- 2018-02-28 18:04:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1437590 | Mikael Dolsten | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | President R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-26 | 86,086 | $0.00 | 201,858 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2018-02-26 | 42,157 | $37.09 | 159,701 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2018-02-27 | 100 | $37.07 | 159,601 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-27 | 100 | $37.02 | 159,501 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-27 | 7,844 | $37.05 | 151,657 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-27 | 9,132 | $37.06 | 142,525 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-27 | 22,291 | $37.04 | 120,234 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-27 | 25,120 | $37.03 | 95,114 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,573 | Indirect | By Rule 16b-3 Plan |
Footnotes
- The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon).
- The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon).
Billionaire Hedge Funds
